The development of PCa is largely dependent on androgen and androgen receptor (AR) signaling; therefore, androgen-deprivation therapy (ADT) has been the mainstay of PCa treatment following surgery and radiotherapy. The gene discussed is AR; the disease is posterior cortical atrophy.